Skip to main content

Find Clinical Trials

Home
Conditions
Smoking Cessation

Clinical trial condition

Smoking Cessation

Explore clinical trials studying Smoking Cessation. Study availability and eligibility vary by location and protocol.

912 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Smoking Cessation trial results

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

NCT00285012

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Denver, Colorado, United States

View all 32 locations

View Trial Details

Completed

Nicotine Patch Trial in Syrian Primary Care Settings

NCT01085032

Conditions: Behavior, Behavioral Symptoms, Chemically-Induced Disorders, +6 more
Locations: Four privately- or NGO-sponsored adult primary care clinics Aleppo, Syria

View Trial Details

Completed

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

NCT00731562

Conditions: Behavior, Bioavailability, Health Behavior, +2 more
Locations: Pfizer Investigational Site East Grand Forks, Minnesota, United States

Pfizer Investigational Site Fargo, North Dakota, United States

View Trial Details

Completed

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

NCT00527150

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Pfizer Investigational Site East Grand Forks, Minnesota, United States

Pfizer Investigational Site Fargo, North Dakota, United States

View Trial Details

Completed

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin

NCT01013454

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Pfizer Investigational Site Brussels, Belgium

View Trial Details

Completed

Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study

NCT00596882

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +4 more
Locations: Transdisciplinary Tobacco Use Research Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.

NCT00738595

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Evotec Study Site 2 Berlin, Germany

Evotec Study Site 3 Bochum, Germany

Evotec Study Site 8 Chemnitz, Germany

Evotec Study Site 4 Dresden, Germany

View Trial Details

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

NCT00661765

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Pfizer Investigational Site Fargo, North Dakota, United States

View Trial Details

Completed

Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch

NCT00458718

Conditions: Behavior, Health Behavior, Smoking Cessation
Locations: Sanofi-Aventis Bridgewater, New Jersey, United States

View Trial Details

Completed

Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)

NCT00432575

Conditions: Behavior, Health Behavior, Smoking Cessation, +1 more
Locations: Sanofi-Aventis Administrative Office Diegem, Belgium

Sanofi-Aventis Administrative Office Paris, France

Sanofi-Aventis Administrative Office Berlin, Germany

Sanofi-Aventis Administrative Office Milan, Italy

View Trial Details